Respiratory Care: Ventilators and Pulmonary Function Assessment Products
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. The two most prevalent respiratory diseases, asthma and COPD, affect more than 480 million people worldwide. The combined global market for ventilators and pulmonary function assessment products totaled more than $1.2bn in 2017, and is expected to climb at a rate of nearly 7% over the forecast period covered by this analysis. In the pulmonary function assessment products segment, disposables accounted for nearly two-thirds of sales and are expected to increase at a much more rapid rate than equipment sales. In the ventilators market, although adult/pediatricventialtorsaccounted for the majority of sales, transport ventilators are expected to experience slightly higher growth over the forecast period. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the markets for ventilators (adult/ pediatric, neonatal, and transport) and pulmonary function assessment products (diagnostic spirometers and PFT devices).